Co-formulated bictegravir, emtricitabine, and tenofovir...

  • Main
  • 2019 / 5
  • Co-formulated bictegravir, emtricitabine, and tenofovir...

Co-formulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial

Stellbrink, Hans-Jürgen, Arribas, José R, Stephens, Jeffrey L, Albrecht, Helmut, Sax, Paul E, Maggiolo, Franco, Creticos, Catherine, Martorell, Claudia T, Wei, Xuelian, Acosta, Rima, Collins, Sean E,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
The Lancet HIV
DOI:
10.1016/S2352-3018(19)30080-3
Date:
May, 2019
File:
PDF, 337 KB
english, 2019
Conversion to is in progress
Conversion to is failed